Disclaimer :
This Product Image is the Property of Arvantis Pharmaceuticals. Using this Product Image Without Prior Permission is Prohibited and Ignoring this Request May Lead to Legal Consequences.
Composition
Sitagliptin Phosphate & Metformin Hydrochloride Tablets
Description
SITARV-M 50/500 (Sitagliptin Phosphate & Metformin Hydrochloride Tablets) is a combination antidiabetic medicine used for the management of Type 2 diabetes mellitus. It combines Sitagliptin, a DPP-4 inhibitor that enhances insulin secretion, with Metformin, which helps reduce glucose production and improves insulin sensitivity. Together, they provide effective blood glucose control when diet and exercise alone are not sufficient. Manufactured under stringent quality standards, Arvantis Pharmaceuticals ensures safe, effective, and reliable tablets for PCD Pharma Franchise, third-party manufacturing, hospital supply, institutional procurement, and bulk distribution across Delhi and India.
Enter your details to start WhatsApp chat
Tablets
Capsules
Softgels
Syrups & Susp.
Injectables
Drops
Cream-lotions
Dry Syrups
Others
